A research team from the University of Minnesota Medical School has identified a strong predictor of ischemic stroke and ...

For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness and safety outcomes.

A research team from the University of Minnesota Medical School has identified a strong predictor of ischemic stroke and ...

The effects and risks of the use of intravenous thrombolysis between 4.5 and 24 hours after the onset of a posterior circulation ischemic stroke are not well studied. In a trial conducted in China ...

You may be familiar with the common signs and symptoms of a stroke: loss of vision, drooping face, weak limbs, and slurred ...

Individuals with asymptomatic hemorrhaging infarction or subarachnoid hemorrhage after receiving endovascular treatment for ...

One in five patients may have a subsequent, more severe stroke within 10 years of experiencing a TIA or minor stroke, underscoring the need for long-term secondary prevention.

A global study establishes long-term risk of stroke. Findings shows one in five people who experience a minor stroke or TIA will have another stroke within 10 years.

A new study described testing the device on a 47-year-old woman with quadriplegia who couldn’t speak for 18 years after a stroke. Doctors implanted it in her brain during surgery as part of a ...

You may already know the common signs of a stroke—sudden vision loss, a drooping face, weak arms or legs, and slurred speech.

The risk for subsequent stroke is persistently high for patients who have had a transient ischemic attack (TIA) or minor stroke.